Under Development

Under Development

(Products marked with an * are P4 opportunities)

  • Abemaciclib
  • Acalabrutinib
  • Acetylcholine
  • Alfaxalone
  • Alpelisib
  • Apalutamide
  • Aripiprazole Lauroxil
  • Asciminib*
  • Avatrombopag
  • Baloxavir marboxil
  • Baricitinib
  • Bedaquiline
  • Bempedoic acid
  • Bensarazide
  • Bictegravir sodium
  • Butorphanol Tartrate
  • Cabozantinib Malate
  • Cannabidiol
  • Carbidopa and Levodopa
  • CBG&CBN
  • Cedazuridine
  • Cevimeline HCL
  • Cyanocobalamine Purified
  • Cysteamine HCL
  • Daprodustat*
  • Deucravacitinib*
  • Diazoxide
  • Doravirine
  • Doxepin HCL
  • Dronabinol
  • Elamipretide
  • Eldecalcitol
  • Eletriptan
  • Elexacaftor
  • Ethynodiol Diacetate
  • Finerenone
  • Fluorometholone Base
  • Folic Acid
  • Ganaxolone*
  • Gefapixant
  • Gestodene
  • Giredestrant
  • Idrocilamide
  • Imepitoin
  • Indacaterol acetate
  • Indomethacin
  • Iron Sucrose
  • Isavuconazole
  • Islatravir
  • Lasmiditan
  • Linagliptin
  • Lumacaftor
  • Lurasidone hydrochloride
  • Mavacamten*
  • Methotrexate
  • Methylene Blue
  • Mirogabalin beylate
  • Nalbuphine HCl
  • Nalfurafine HCL
  • Naloxone
  • Naltrexone Base
  • Naltrexone HCL
  • Nilotinib
  • Niraparib
  • Noretisterone acetate
  • Noroxymorphone
  • Olodaterol
  • Opicapone*
  • Ozanimod*
  • Perampanel
  • Phythonadione (Vit.K1)
  • Pilocarpine
  • Pimobendan
  • Pirfenidone
  • Pomalidomide
  • Regorafenib Tosilate
  • Relugolix*
  • Ritlecitinib
  • Romifidine
  • Ripasudil HCL Dihydrate
  • Roxadustat
  • Samidorphan
  • Selenious Acid
  • Semaglutide
  • Setmelanotide*
  • Solriamfetol
  • Sorafenib Tosilate
  • Sotagliflozin
  • Salbutamol Sulfate
  • Staurosporine
  • Suvorexant
  • Tafamidis Meglumine
  • Taitirelin
  • Tapinarof*
  • Tecovirimat
  • Teduglutide
  • Teneligliptin hydrobromide hydrate
  • Tezacaftor
  • Tipiracil
  • Tirzepatide*
  • Tixocortol Pivalate
  • Trilaciclib*
  • Ubrogepant
  • Umeclidinium bromide
  • Valbenazine Tosylate
  • Valproate Semisodium
  • Vazegpant biohaven
  • Venetoclax
  • Vibegron
  • Viloxazine*
  • Voclosporin*
  • Vonoprazan
  • Voxelotor
  • Zanubrutinib
  • Zavegepant*
  • Zuranolone

Enquire Now

Enquire for professional healthcare solutions.

Download Product LIst
API'sCAS NumberCountry of OriginRC noValid Upto
Clindamycin HCl IP/BP/EP /USP21462-39-5ChinaBD-31619-Sep-24
Clindamycin Phosphate IP/USP24729-96-2ChinaBD-31619-Sep-24
Topotecan HCl119413-54-6TaiwanBD-0022125-Mar-24
Docetaxel Anhydrous IP114977-28-5TaiwanBD-0022125-Mar-24
Azacitidine IP320-67-2TaiwanBD-0022125-Mar-24
Paclitaxel IP33069-62-4TaiwanBD-00223526-Dec-24
Galantamine HBr IP1953-04-4TaiwanBD-00223526-Dec-24
Irinotecan HCl Trihydrate IP136572-09-3TaiwanBD-00223526-Dec-24
Gemcitabine HCl IP122111-03-9TaiwanBD-00223526-Dec-24
Doxorubicin HCl IP25316-40-9GermanyBD-0025241-Jul-24
Epirubicin HCl EP56390-09-1GermanyBD-0025241-Jul-24
Mometasone Furoate IP83919-23-7ItalyBD-002426Under Renewal
Moxonidine micronized EP (non-sterile)75438-57-2Czech RepublicBD-103620-Jun-24
Alfuzosin HCl IP81403-68-1Czech RepublicBD-103620-Jun-24
Tacrolimus IP/USP104987-11-3Taiwan00267129-May-26

Trimetazidine Dihydrochloride BP, EP, JP

Structural formula

CAS No : 13171-25-0

Molecular formula : C14H22N2O3, 2HCl

Molecular weight : 339.3

Category : Antianginal Drug

Ranolazine

Structural formula

CAS No : 95635-55-5

Molecular formula : C24H33N3O4

Molecular weight : 427.536

Category : Antianginal Drug

Chlorthalidone IP, USP, BP, EP

Structural formula

CAS No : 77-36-1

Molecular formula : C14H11CLN2O4S

Molecular weight : 338.76

Category : Diuretic Drug